促红细胞生成素肝细胞(Eph)受体
肿瘤微环境
免疫系统
生物
以法林
癌症研究
血管生成
EPH受体A2
转移
受体
免疫学
获得性免疫系统
癌症
细胞生物学
信号转导
受体酪氨酸激酶
生物化学
遗传学
作者
Peter W. Janes,Mary E. Vail,Matthias Ernst,Andrew M. Scott
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2020-11-11
卷期号:81 (4): 801-805
被引量:56
标识
DOI:10.1158/0008-5472.can-20-3047
摘要
The tumor microenvironment (TME) promotes tumor development via complex intercellular signaling, aiding tumor growth and suppressing immunity. Eph receptors (Eph) and their ephrin ligands control cell interactions during normal development, and reemerge in tumors and the TME, where they are implicated in invasion, metastasis, and angiogenesis. Recent studies also indicate roles for Ephs in suppressing immune responses by controlling tumor interactions with innate and adaptive immune cells within the TME. Accordingly, inhibiting these functions can promote immune response and efficacy of immune checkpoint inhibition. This research highlights Ephs as potential targets to enhance efficacy of immune-based therapies in patients with cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI